Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Empery Asset Management

Latest statistics and disclosures from Empery Asset Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are XFOR, EMPD, DTIL, IMPP, VENU, and represent 81.02% of Empery Asset Management's stock portfolio.
Added to shares of these 10 stocks: VENU, USEG, SCYX, CYN, Jaguar Uranium Cl A Ord, Satellos Bioscience, URG, PMN, SLE, Briacell Therapeutics Corp.
Started 13 new stock positions in Briacell Therapeutics Corp, NSRX, SLE, URG, CYN, PRZO, USEG, VENU, Satellos Bioscience, ABTS. SCYX, PMN, Jaguar Uranium Cl A Ord.
Reduced shares in these 10 stocks: IMRX (-$18M), IMPP (-$9.9M), ADUR (-$5.9M), EOSE, CRML, SRZN, DTIL, KZIA, PROF, RBNE.
Sold out of its positions in ADUR, ALUR, EOSE, IMRX, KZIA, PROF, TARA, PCTTW, Super League Enterprise, SRZN. XLO, RBNE.
Empery Asset Management was a net seller of stock by $-35M.
Empery Asset Management has $83M in assets under management (AUM), dropping by -26.79%.
Central Index Key (CIK): 0001469336

Tip: Access up to 7 years of quarterly data

Positions held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Empery Asset Management

Empery Asset Management holds 32 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
X4 Pharmaceuticals Com New (XFOR)	44.5	$37M		8.9M	4.13	View chart
Empery Digital Com New (EMPD)	14.9	$12M		2.9M	4.23	View chart
Precision Biosciences Com New (DTIL)	13.0	$11M	-10%	2.0M	5.50	View chart
Imperial Pete Com New (IMPP)	4.5	$3.8M	-72%	878k	4.28	View chart
Venu Hldg Corp (VENU)	4.0	$3.3M	NEW	1.0M	3.31	View chart
Tenaya Therapeutics (TNYA)	3.6	$3.0M	-20%	4.3M	0.69	View chart
Us Energy Corp Wyoming (USEG)	2.0	$1.7M	NEW	1.9M	0.88	View chart
Scynexis Com New (SCYX)	2.0	$1.7M	NEW	1.8M	0.92	View chart
Cyngn Inc Com Par $0 00001 (CYN)	1.9	$1.6M	NEW	958k	1.66	View chart
Jaguar Uranium Corp Cl A Com Shs	1.6	$1.3M	NEW	488k	2.75	View chart
Satellos Bioscience	1.6	$1.3M	NEW	230k	5.63	View chart
Critical Metals Corp Pubco Ord Shs (CRML)	1.3	$1.0M	-73%	132k	7.94	View chart
Ur-energy (URG)	1.1	$924k	NEW	620k	1.49	View chart
Promis Neurosciences Com Shs (PMN)	0.9	$767k	NEW	60k	12.70	View chart
Super League Enterprise Com New (SLE)	0.6	$492k	NEW	133k	3.70	View chart
Talphera Com New (TLPH)	0.5	$441k	-55%	591k	0.75	View chart
Benitec Biopharma Com New (BNTC)	0.4	$324k	-45%	30k	10.65	View chart
Briacell Therapeutics Corp *w Exp 01/15/203	0.4	$309k	NEW	300k	1.03	View chart
Abits Group Shs New (ABTS)	0.3	$266k	NEW	173k	1.54	View chart
Parazero Technologies SHS (PRZO)	0.3	$218k	NEW	282k	0.77	View chart
Nasus Pharma Ord Shs (NSRX)	0.1	$102k	NEW	46k	2.22	View chart
Briacell Therapeutics Corp *w Exp 99/99/999 (BCTXZ)	0.1	$93k		667k	0.14	View chart
Nutriband *w Exp 99/99/999 (NTRBW)	0.1	$45k		40k	1.12	View chart
Maris Tech *w Exp 02/04/202 (MTEKW)	0.1	$45k		298k	0.15	View chart
Renatus Tactical Acquis *w Exp 05/15/203 (RTACW)	0.0	$23k		50k	0.46	View chart
Neurosense Therapeutics *w Exp 11/10/202 (NRSNW)	0.0	$20k		100k	0.20	View chart
Spectral Ai *w Exp 09/11/202 (MDAIW)	0.0	$19k		33k	0.56	View chart
Cea Industries *w Exp 02/11/202 (BNCWW)	0.0	$15k		500k	0.03	View chart
Medicus Pharma *w Exp 11/15/202 (MDCXW)	0.0	$12k		12k	0.95	View chart
Nexera Technologies *w Exp 08/26/202 (NEXRW)	0.0	$6.1k		361k	0.02	View chart
Nexgel *w Exp 12/27/202 (NXGLW)	0.0	$5.4k		90k	0.06	View chart
Fgi Industries *w Exp 99/99/999 (FGIWW)	0.0	$2.7k		84k	0.03	View chart

Past Filings by Empery Asset Management

SEC 13F filings are viewable for Empery Asset Management going back to 2021

Empery Asset Management 2026 Q1 filed May 8, 2026
Empery Asset Management 2025 Q4 filed Feb. 11, 2026
Empery Asset Management 2022 Q3 filed Nov. 14, 2022
Empery Asset Management 2022 Q2 filed Aug. 12, 2022
Empery Asset Management 2022 Q1 filed May 16, 2022
Empery Asset Management 2021 Q4 filed Feb. 11, 2022

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z